These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25559731)

  • 1. Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.
    Beck A; Quirke KP; Gamelli RL; Mosier MJ
    J Burn Care Res; 2015; 36(1):167-77. PubMed ID: 25559731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Does SCORTEN Score?
    Zavala S; O'Mahony M; Joyce C; Baldea AJ
    J Burn Care Res; 2018 Jun; 39(4):555-561. PubMed ID: 29789855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of histologic features of toxic epidermal necrolysis.
    Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
    J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
    Bansal S; Garg VK; Sardana K; Sarkar R
    Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
    Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis.
    Guégan S; Bastuji-Garin S; Poszepczynska-Guigné E; Roujeau JC; Revuz J
    J Invest Dermatol; 2006 Feb; 126(2):272-6. PubMed ID: 16374461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Mechanical Ventilation and Mortality: Early and Late Indicators in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Beck A; Cooney R; Gamelli RL; Mosier MJ
    J Burn Care Res; 2016; 37(1):e47-55. PubMed ID: 26594858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.
    Sekula P; Liss Y; Davidovici B; Dunant A; Roujeau JC; Kardaun S; Naldi L; Schumacher M; Mockenhaupt M
    J Burn Care Res; 2011; 32(2):237-45. PubMed ID: 21228709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
    Kannenberg SM; Jordaan HF; Koegelenberg CF; Von Groote-Bidlingmaier F; Visser WI
    QJM; 2012 Sep; 105(9):839-46. PubMed ID: 22543685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.
    Cartotto R; Mayich M; Nickerson D; Gomez M
    J Burn Care Res; 2008; 29(1):141-6. PubMed ID: 18182912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
    Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
    J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
    J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.